| Bioactivity | KCNQ1 activator-1 (compound 3) is a potent activator of KCNQ1 channel. KCNQ1 activator-1 has the potential for the research of long QT syndrome (LQTS)[1]. | ||||||||||||
| Name | KCNQ1 activator-1 | ||||||||||||
| CAS | 1008671-38-2 | ||||||||||||
| Formula | C22H23N3O4S2 | ||||||||||||
| Molar Mass | 457.57 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Mattmann ME, et al. Identification of (R)-N-(4-(4-methoxyphenyl)thiazol-2-yl)-1-tosylpiperidine-2-carboxamide, ML277, as a novel, potent and selective K(v)7.1 (KCNQ1) potassium channel activator. Bioorg Med Chem Lett. 2012;22(18):5936-5941. |
KCNQ1 activator-1
CAS: 1008671-38-2 F: C22H23N3O4S2 W: 457.57
KCNQ1 activator-1 (compound 3) is a potent activator of KCNQ1 channel. KCNQ1 activator-1 has the potential for the resea
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.